Private Wealth Management Group’s Blueprint Medicines BPMC Stock Holding History

Private Wealth Management Group’s Portfolio BPMC Stock Details BPMC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-49	Closed	-$6.28K	–	1490
2025 Q2	$6.28K	Hold	49	–	–	﹤0.01%	659
2025 Q1	$4.34K	Hold	49	–	–	﹤0.01%	784
2024 Q4	$4.27K	Hold	49	–	–	﹤0.01%	809
2024 Q3	$4.53K	Hold	49	–	–	﹤0.01%	771
2024 Q2	$5.28K	Hold	49	–	–	﹤0.01%	684
2024 Q1	$4.65K	Hold	49	–	–	﹤0.01%	642
2023 Q4	$4.52K	Buy	+49	New	+$3.17K	﹤0.01%	664

Other funds holding BPMC

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Private Wealth Management Group's BPMC Position: Q3 2025 in Review

Private Wealth Management Group sold out of Blueprint Medicines (BPMC) in Q3 2025, closing a stake of 49 shares — an estimated $6.28K sold.

Private Wealth Management Group first reported a position in BPMC in Q4 2023 and held it in 7 quarters. The position peaked at $6.28K in Q2 2025. 5 funds tracked by Wall St. Rank hold BPMC as of Q3 2025.

Private Wealth Management Group reported no remaining Blueprint Medicines position as of Q3 2025 after selling out during the quarter.
Private Wealth Management Group sold 49 Blueprint Medicines shares in Q3 2025, an estimated $6.28K.
Private Wealth Management Group first reported a position in Blueprint Medicines in Q4 2023 and held it in 7 quarters.
Private Wealth Management Group's Blueprint Medicines position peaked at $6.28K in Q2 2025.
5 funds tracked by Wall St. Rank held Blueprint Medicines as of Q3 2025.

Based on Private Wealth Management Group's 13F filing for Q3 2025, filed 17 Oct 2025.